The "French Sunshine Act", also known as the Loi Bertrand, aims to bring about greater transparency in the relationship between health care providers (HCPs) and the Life Sciences industry. With subject matter expertise in transparency reporting and data analytics, companies can extract valuable information from this data, including:
- Top Key Opinion Leader (KOL) metrics
- Key Risk Indicators
- Improved Resource Allocation
- Insights into Commercial Effectiveness
- Overview of Spending by Categories, and
- Enhanced Compliance Decision Making
Download this new IQVIA Commercial Compliance White Paper to learn more.